ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

NCT03689712 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

455

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Mucositis

Interventions

DRUG: GC4419 90mg
DRUG: Placebo

Sponsor

Galera Therapeutics, Inc.